📰 Lipids News
Page 62 - Lipids News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lipids. Real-time updates on events, politics, business and more.
August 16, 2022
A large cohort study implicates gut microbiome metabolites as the key link between red meat consumption and atherosclerotic cardiovascular disease.
August 16, 2022
In this Perspective, Dimitrios Sagris, Stephanie Harrison, and Gregory Lip discuss new evidence concerning the paradoxical relationship between circulating lipids and atrial fibrillation.
August 15, 2022
A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Therefore, various anticancer drugs targeting TRAIL receptors have been developed and gained great attention as a promising cancer therapeutics, but a certain population of cancer patients does not respond to the therapy.
August 12, 2022
Assessment of pericoronary fat volume and attenuation index showed potential for diagnosis and assessment of coronary heart disease, but not necessarily coronary lesions.
August 12, 2022
A fourth of patients received inappropriate doses of direct oral anticoagulants for atrial fibrillation in a prospective study, for reasons sometimes related to use or nonuse of certain other drugs.
August 12, 2022
Atherosclerotic risk factors present in children as young as 29 days are associated with significant risk for arterial ischemic stroke in the fourth and fifth decades of life, a new study suggests.
August 11, 2022
Scientists of the department of Advanced Organ Bioengineering and Therapeutics (Faculty of S&T, TechMed Centre) recently published a novel cancer immune therapy in the scientific journal Nature Communications.
August 11, 2022
Mozhu Ding and colleagues investigate investigate the association between blood lipid levels in midlife and subsequent risk of new-onset atrial fibrillation in Sweden.
August 11, 2022
Patients with rheumatoid arthritis are at greater risk for infection if theyre treated with tofacitinib than with a tumor necrosis factor inhibitor (TNFi), according to an industry-funded study.
August 11, 2022
South Asians, from India and elsewhere on the subcontinent, living in America have a higher risk of dying from atherosclerotic disease plus type 2 diabetes than other Americans.